Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding*

Oligonucleotides have been extensively studied as antisense or antigene agents that can potentially modulate the expression of specific genes. These strategies rely on sequence-specific hybridization of the oligonucleotide to mRNA or genomic DNA. Recently, it has become clear that oligonucleotides often have biological activities that cannot be attributed to their sequence-specific interactions with nucleic acids. Here we describe a series of guanosine-rich phosphodiester oligodeoxynucleotides that strongly inhibit proliferation in a number of human tumor cell lines. The presence of G-quartets in the active oligonucleotides is demonstrated using an UV melting technique. We show that G-rich oligonucleotides bind to a specific cellular protein and that the biological activity of the oligonucleotides correlates with binding to this protein. The G-rich oligonucleotide-binding protein was detected in both nuclear and cytoplasmic extracts and in proteins derived from the plasma membrane of cells. We present strong evidence that this protein is nucleolin, a multifunctional phosphoprotein whose levels are related to the rate of cell proliferation. Our results indicate that binding of G-rich oligonucleotides to nucleolin may be responsible for their non-sequence-specific effects. Furthermore, these oligonucleotides represent a new class of potentially therapeutic agents with a novel mechanism of action.

[1]  J. Labbé,et al.  Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase , 1990, Molecular and cellular biology.

[2]  M Yarus,et al.  Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.

[3]  G. Hartmann,et al.  Oligodeoxynucleotides Enhance Lipopolysaccharide-Stimulated Synthesis of Tumor Necrosis Factor: Dependence on Phosphorothioate Modification and Reversal by Heparin , 1996, Molecular medicine.

[4]  S. Fang,et al.  The self-cleaving activity of nucleolin determines its molecular dynamics in relation to cell proliferation. , 1993, Experimental cell research.

[5]  Alastair I.H. Murchie,et al.  Retinoblastoma susceptibility genes contain 5' sequences with a high propensity to form guanine-tetrad structures , 1992, Nucleic Acids Res..

[6]  S. Pongor,et al.  Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation. , 1995, Gene.

[7]  S. Capaccioli,et al.  Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. , 1993, Biochemical and biophysical research communications.

[8]  P. Bouvet,et al.  Nucleolin functions in the first step of ribosomal RNA processing , 1998, The EMBO journal.

[9]  E. Dam,et al.  Identification of V3 Loop-binding Proteins as Potential Receptors Implicated in the Binding of HIV Particles to CD4+Cells* , 1998, The Journal of Biological Chemistry.

[10]  P. Bouvet,et al.  Structure and functions of nucleolin. , 1999, Journal of cell science.

[11]  S. Ross,et al.  The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Jean-Louis Mergny,et al.  Following G‐quartet formation by UV‐spectroscopy , 1998, FEBS letters.

[13]  C. Semenkovich,et al.  A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. , 1990, Biochemistry.

[14]  Aaron Klug,et al.  Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops , 1989, Nature.

[15]  W. Sundquist,et al.  Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Chen,et al.  Increased stability of nucleolin in proliferating cells by inhibition of its self-cleaving activity. , 1991, The Journal of biological chemistry.

[17]  V. Vlassov,et al.  Transport of oligonucleotides across natural and model membranes. , 1994, Biochimica et biophysica acta.

[18]  C. Hunt,et al.  Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-gamma-induced major histocompatibility complex class I and intercellular adhesion molecule-1. , 1994, The Journal of biological chemistry.

[19]  Shin C. Chang,et al.  The Nucleolin Binding Activity of Hepatitis Delta Antigen Is Associated with Nucleolus Targeting* , 1998, The Journal of Biological Chemistry.

[20]  G. Dreyfuss,et al.  Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n , 1993, Molecular and cellular biology.

[21]  V. Kinzel,et al.  Major cell surface-located protein substrates of an ecto-protein kinase are homologs of known nuclear proteins. , 1994, Biochemistry.

[22]  R. Rando,et al.  Inhibition of High Affinity Basic Fibroblast Growth Factor Binding by Oligonucleotides (*) , 1995, The Journal of Biological Chemistry.

[23]  W. J. Irwin,et al.  A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells. , 1996, Molecular pharmacology.

[24]  D. Patel,et al.  Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. , 1993, Structure.

[25]  J. Labbé,et al.  Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase , 1990, Cell.

[26]  H. Bourbon,et al.  Nucleolin, the major nucleolar protein of growing eukaryotic cells: an unusual protein structure revealed by the nucleotide sequence. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Loeb,et al.  The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Bouvet,et al.  Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA. , 1996, Journal of molecular biology.

[29]  M. Schwab,et al.  Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. , 1997, European journal of cell biology.

[30]  N. Goldstein,et al.  Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Stein,et al.  Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.

[32]  N. Lemoine,et al.  Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. , 1995, British Journal of Cancer.

[33]  K. Sonehara,et al.  Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[34]  P. Sarnow,et al.  Viral Ribonucleoprotein Complex Formation and Nucleolar-Cytoplasmic Relocalization of Nucleolin in Poliovirus-Infected Cells , 1998, Journal of Virology.

[35]  N. Maizels,et al.  G4 DNA Binding by LR1 and Its Subunits, Nucleolin and hnRNP D, A Role for G-G pairing in Immunoglobulin Switch Recombination* , 1999, The Journal of Biological Chemistry.

[36]  J. White,et al.  Phosphorothioate-capped antisense oligonucleotides to Ras GAP inhibit cell proliferation and trigger apoptosis but fail to downregulate GAP gene expression. , 1996, Biochemical and biophysical research communications.

[37]  C. Stein How to design an antisense oligodeoxynucleotide experiment: a consensus approach. , 1998, Antisense & nucleic acid drug development.

[38]  S. Crooke,et al.  An overview of progress in antisense therapeutics. , 1998, Antisense & nucleic acid drug development.

[39]  T. Tsuruo,et al.  ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. , 1988, The Journal of biological chemistry.

[40]  T. Kohwi-Shigematsu,et al.  Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential , 1995, Molecular and cellular biology.

[41]  D. M. Morgan,et al.  Tetrazolium (MTT) assay for cellular viability and activity. , 1998, Methods in molecular biology.

[42]  A. Branch,et al.  A good antisense molecule is hard to find , 1998 .

[43]  W. Gilbert,et al.  Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis , 1988, Nature.

[44]  H. Kleinman,et al.  A 110‐kD nuclear shuttling protein, nucleolin, binds to the neurite‐promoting IKVAV site of laminin‐1 , 1995, Journal of neuroscience research.

[45]  N. Maizels,et al.  High Affinity Interactions of Nucleolin with G-G-paired rDNA* , 1999, The Journal of Biological Chemistry.

[46]  E. López-Granados,et al.  Cellular Adhesion Mediated by Factor J, a Complement Inhibitor , 1998, The Journal of Biological Chemistry.

[47]  F. Quadrifoglio,et al.  Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding proteins. , 1998, European journal of biochemistry.

[48]  D. L. Sokol,et al.  Nucleic acid therapeutics: state of the art and future prospects. , 1998, Blood.

[49]  D. Treré,et al.  The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[50]  Y. Cheng,et al.  Identification of two oligodeoxyribonucleotide binding proteins on plasma membranes of human cell lines. , 1996, Biochemical pharmacology.

[51]  D. Hernandez-Verdun,et al.  Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. , 1994, Experimental cell research.

[52]  T. Abe,et al.  Contiguous Four‐guanosine Sequence in c‐myc Antisense Phosphorothioate Oligonucleotides Inhibits Cell Growth on Human Lung Cancer Cells: Possible Involvement of Cell Adhesion Inhibition , 1997, Japanese journal of cancer research : Gann.

[53]  N. Tuteja,et al.  Nucleolin: a multifunctional major nucleolar phosphoprotein. , 1998, Critical reviews in biochemistry and molecular biology.

[54]  G. Zhou,et al.  Nucleolin is a protein kinase C-zeta substrate. Connection between cell surface signaling and nucleus in PC12 cells. , 1997, The Journal of biological chemistry.

[55]  E. Krebs,et al.  The Physical Association of Casein Kinase 2 with Nucleolin* , 1996, The Journal of Biological Chemistry.

[56]  S. Agrawal,et al.  Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo. , 1998, Antisense & nucleic acid drug development.

[57]  D. Tidd,et al.  The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus. , 1998, The Journal of endocrinology.

[58]  Lyuba Benimetskaya,et al.  Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide , 1997, Nucleic Acids Res..

[59]  R. Foisner,et al.  Two‐dimensional electrophoresis reveals a nuclear matrix‐associated nucleolin complex of basic isoelectric point , 1997, Electrophoresis.